Table 1 Demographic and clinical... | American Society of Hematology

Table 1

Demographic and clinical characteristics

	HIV⁺/TB⁺ IRIS (n = 37)	HIV⁺/TB⁺ non-IRIS (n = 91)	HIV⁺/TB⁻ (n = 49)
Sex
Male	23 (62.2%)	57 (62.6%)
Female	14 (37.8%)	34 (37.4%)
Median age, y (IRQ)	33 (28-38)	36 (31-44)
CD4, cells/mm³
n (%)	37 (100.0)	91 (100.0)	34 (69.4)
Median (IQR)	27 (9-47)	27 (10-68)	85 (29-165)*
Viral load, log copies/mL
n (%)	37 (100.0)	91 (100.0)	34 (65.4)
Median (IQR)	5.76 (5.41-5.99)	5.50 (5.10-5.95)	5.40 (4.77-5.71)†
BMI, kg/m²
Median (IQR)	16.0 (15.4-18.4)	16.8 (15.6-19.0)
Identification
TB	33 (89.2)	62 (68.1)
Atypical myco	0	2 (2.2)
Unknown	4 (10.8)	27 (29.7)
TB disseminated
Yes	16 (43.2)	16 (17.6)‡
Total NK cells, %
n (%)	32 (86.5)	78 (85.7)	49 (100.0)
Median (IQR)	18.0 (10.0-28.3)	20.4 (11.4-25.4)	17.5 (12.5-22.5)

	HIV⁺/TB⁺ IRIS (n = 37)	HIV⁺/TB⁺ non-IRIS (n = 91)	HIV⁺/TB⁻ (n = 49)
Sex
Male	23 (62.2%)	57 (62.6%)
Female	14 (37.8%)	34 (37.4%)
Median age, y (IRQ)	33 (28-38)	36 (31-44)
CD4, cells/mm³
n (%)	37 (100.0)	91 (100.0)	34 (69.4)
Median (IQR)	27 (9-47)	27 (10-68)	85 (29-165)*
Viral load, log copies/mL
n (%)	37 (100.0)	91 (100.0)	34 (65.4)
Median (IQR)	5.76 (5.41-5.99)	5.50 (5.10-5.95)	5.40 (4.77-5.71)†
BMI, kg/m²
Median (IQR)	16.0 (15.4-18.4)	16.8 (15.6-19.0)
Identification
TB	33 (89.2)	62 (68.1)
Atypical myco	0	2 (2.2)
Unknown	4 (10.8)	27 (29.7)
TB disseminated
Yes	16 (43.2)	16 (17.6)‡
Total NK cells, %
n (%)	32 (86.5)	78 (85.7)	49 (100.0)
Median (IQR)	18.0 (10.0-28.3)	20.4 (11.4-25.4)	17.5 (12.5-22.5)

IQR indicates interquartile range.

P < .001 when comparing HIV⁺/TB⁺ IRIS and HIV⁺/TB⁺ non-IRIS with HIV⁺/TB⁻.

P = .004 when comparing HIV⁺/TB⁺ IRIS with HIV⁺/TB⁻.

P = .002 when comparing HIV⁺/TB⁺ IRIS with HIV⁺/TB⁺ non-IRIS.